Funded Tech Companies

Flare Therapeutics

Flare Therapeutics is a leading biopharmaceutical tech company, based in Cambridge. Financial backing came from Eli Lilly and Company, Pfizer Venture Investments and Boxer Capital.

Company Overview

Contact Information

Company Background Information

Overview

Flare is lighting up a new therapeutic space with an entirely different approach to decipher the biology of transcription factors to develop small molecule medicines. Based on insights from the seminal work of our scientific founders, Flare's team is leveraging the power of 'switch sites' as druggable regions that hold the control for predictable and profound changes in DNA transcription, and therefore, gene expression. Our drug discovery to target 'switch sites' has rapidly advanced, resulting in our pipeline of drug programs that address well-validated transcription factors, initially focused on precision oncology.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

3/22/2023

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Amit Rakhit

        

Chief Operating Officer

Daphne Karydas

        

Chief Scientific Officer

Robert Sims

        

Vice President

Jim Audia

        

Company Investors

• Eli Lilly and Company (Eli Lilly)
• Pfizer Venture Investments (Irena Melnikova)
• Boxer Capital
• Third Rock Ventures
• GordonMD Global Investments (Craig Gordon)
• Agent Capital
• Invus Opportunities
• Nextech Invest
• Shangbay Capital
• Pavilion Capital
• Novartis
• Casdin Capital
• Memorial Sloan Kettering Cancer Center
• Eventide Asset Management

Browse more funded tech companies:

Flare | Flaregames

Share this article

About Our VC & M&A Database

The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary